Li Y, Yong D G, Geng B Q, Gu G G
Department of Pharmacology, Zhejiang Medical University, Hangzhou, China.
Zhongguo Yao Li Xue Bao. 1991 Sep;12(5):453-6.
Trifluoperazine (TFP) 5, 10, 20 mg.kg-1 ig inhibited the formation of gastric ulcers induced by pyloric ligation, stress and indomethacin in rats and showed dose-effect dependence. TFP 10, 20 mg.kg-1 ig depressed the secretion of gastric juice, acid, and pepsin, but TFP 5, 10, 20 mg.kg-1 ig had no influence on the pepsin activity. TFP 20 mg.kg-1 ig inhibited the gastric H+, K(+)-ATPase activity of both stress and indomethacin ulcers in rats in vivo, and the gastric H+, K(+)-ATPase activity was also inhibited by TFP 50 mumol.L-1 in vitro. The results suggested that the inhibition of gastric H+, K(+)-ATPase activity and gastric secretion might be related to the antiulcer mechanism of TFP.
三氟拉嗪(TFP),剂量为5、10、20毫克/千克,腹腔注射,可抑制大鼠幽门结扎、应激和消炎痛诱导的胃溃疡形成,并呈现剂量效应依赖性。TFP剂量为10、20毫克/千克,腹腔注射,可抑制胃液、胃酸和胃蛋白酶的分泌,但TFP剂量为5、10、20毫克/千克,腹腔注射,对胃蛋白酶活性无影响。TFP剂量为20毫克/千克,腹腔注射,可抑制大鼠体内应激和消炎痛溃疡的胃H⁺,K⁺-ATP酶活性,在体外,50微摩尔/升的TFP也可抑制胃H⁺,K⁺-ATP酶活性。结果表明,抑制胃H⁺,K⁺-ATP酶活性和胃分泌可能与TFP的抗溃疡机制有关。